GNPS Annotation	Chemical	Attribute	Term	Observations	Total Files  	Percentage
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	acetonitrile-isopropanol-water (3:3:2)	6	6	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	acetonitrile-water (7:3)	6	6	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	methanol (100%)	6	6	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	methanol-acetonitrile (3:7)	6	6	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	methanol-water (3:2)	6	6	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	methanol-water (4:1)	6	6	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	methanol-water (7:3)	6	6	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	methanol-water (9:1)	3	3	1
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HumanPopulationDensity	not applicable	61	63	0.968253968
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	YearOfAnalysis	2019	61	63	0.968253968
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	YearOfAnalysis	2016	30	31	0.967741935
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	Adolescence (8 yrs < x <= 18 yrs)	151	169	0.893491124
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	diabetes mellitus	49	56	0.875
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HealthStatus	chronic illness	119	140	0.85
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	inflammatory bowel disease	70	84	0.833333333
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	acetonitrile (100%)	5	6	0.833333333
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	ethanol-water (1:1)	5	6	0.833333333
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	Middle Adulthood (45 yrs < x <= 65 yrs)	736	933	0.788853162
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	disease NOS	1125	1428	0.787815126
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	Later Adulthood (>65 yrs)	251	325	0.772307692
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HealthStatus	unhealthy (NOS)	1240	1686	0.735468565
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	Early Adulthood (18 yrs < x <= 45 yrs)	727	995	0.730653266
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	Early Childhood (2 yrs < x <=8 yrs)	67	93	0.720430108
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	MassSpectrometer	impact|MS:1002077	296	447	0.662192394
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleCollectionMethod	"solid material, fresh"	257	397	0.647355164
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	methanol-water (1:1)	407	634	0.641955836
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HumanPopulationDensity	Urban	2113	3470	0.608933718
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	Crohn's disease	118	197	0.598984772
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	not collected	435	735	0.591836735
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	ulcerative colitis	78	136	0.573529412
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	YearOfAnalysis	2018	421	748	0.562834225
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	BiologicalSex	female	1309	2372	0.551854975
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleTypeSub1	tissue	76	138	0.550724638
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	BiologicalSex	male	1192	2264	0.526501767
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	MassSpectrometer	impact HD|MS:1002667	2023	3971	0.509443465
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	TermsofPosition	not applicable	2518	5048	0.49881141
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	IonizationSourceAndPolarity	electrospray ionization (positive)	2532	5081	0.498327101
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	ChromatographyAndPhase	reverse phase (C18)	2532	5114	0.495111459
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	NCBITaxonomy	9606|Homo sapiens	2532	5114	0.495111459
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleType	animal	2532	5114	0.495111459
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	UBERONBodyPartName	feces	2532	5114	0.495111459
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleTypeSub1	biofluid	2456	4976	0.493569132
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleCollectionMethod	"swabs, dry"	2266	4696	0.48253833
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	YearOfAnalysis	2017	2020	4272	0.472846442
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleExtractionMethod	ethanol-water (9:1)	2070	4423	0.468008139
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HumanPopulationDensity	not collected	192	443	0.433408578
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	SampleCollectionMethod	"solid material, frozen"	9	21	0.428571429
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	no disease reported	1068	2960	0.360810811
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HealthStatus	healthy	1068	2960	0.360810811
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HealthStatus	not applicable	91	262	0.347328244
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	MassSpectrometer	Q Exactive|MS:1001911	213	696	0.306034483
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	not specified	1	4	0.25
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	primary bacterial infectious disease	14	66	0.212121212
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HealthStatus	acute illness	14	66	0.212121212
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	TermsofPosition	not collected	14	66	0.212121212
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	sleep deprivation	9	55	0.163636364
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	HumanPopulationDensity	Rural	166	1138	0.145869947
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	Infancy (<2 yrs)	164	1859	0.088219473
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	BiologicalSex	not collected	31	477	0.064989518
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	DOIDCommonName	not applicable	1	132	0.007575758
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	BiologicalSex	not applicable	0	1	0
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	IonizationSourceAndPolarity	electrospray ionization (negative)	0	33	0
Spectral Match to 12-Ketodeoxycholic acid from NIST14	12-Ketodeoxycholic acid	LifeStage	not applicable	0	1	0
Cholic acid	Cholic acid	BiologicalSex	not applicable	1	1	1
Cholic acid	Cholic acid	LifeStage	not applicable	1	1	1
Cholic acid	Cholic acid	HumanPopulationDensity	Rural	1077	1138	0.946397188
Cholic acid	Cholic acid	DOIDCommonName	Crohn's disease	156	197	0.791878173
Cholic acid	Cholic acid	DOIDCommonName	ulcerative colitis	106	136	0.779411765
Cholic acid	Cholic acid	LifeStage	Infancy (<2 yrs)	1420	1859	0.763851533
Cholic acid	Cholic acid	MassSpectrometer	impact|MS:1002077	332	447	0.742729306
Cholic acid	Cholic acid	SampleCollectionMethod	"solid material, fresh"	263	397	0.662468514
Cholic acid	Cholic acid	DOIDCommonName	diabetes mellitus	36	56	0.642857143
Cholic acid	Cholic acid	HumanPopulationDensity	not collected	281	443	0.634311512
Cholic acid	Cholic acid	SampleExtractionMethod	methanol-water (1:1)	379	634	0.597791798
Cholic acid	Cholic acid	DOIDCommonName	no disease reported	1590	2960	0.537162162
Cholic acid	Cholic acid	HealthStatus	healthy	1590	2960	0.537162162
Cholic acid	Cholic acid	YearOfAnalysis	2018	398	748	0.532085561
Cholic acid	Cholic acid	SampleCollectionMethod	"solid material, frozen"	11	21	0.523809524
Cholic acid	Cholic acid	LifeStage	not collected	369	735	0.502040816
Cholic acid	Cholic acid	LifeStage	not specified	2	4	0.5
Cholic acid	Cholic acid	BiologicalSex	male	1049	2264	0.463339223
Cholic acid	Cholic acid	DOIDCommonName	primary bacterial infectious disease	30	66	0.454545455
Cholic acid	Cholic acid	HealthStatus	acute illness	30	66	0.454545455
Cholic acid	Cholic acid	TermsofPosition	not collected	30	66	0.454545455
Cholic acid	Cholic acid	SampleTypeSub1	biofluid	2173	4976	0.436696141
Cholic acid	Cholic acid	IonizationSourceAndPolarity	electrospray ionization (positive)	2173	5081	0.427671718
Cholic acid	Cholic acid	ChromatographyAndPhase	reverse phase (C18)	2173	5114	0.424912006
Cholic acid	Cholic acid	NCBITaxonomy	9606|Homo sapiens	2173	5114	0.424912006
Cholic acid	Cholic acid	SampleType	animal	2173	5114	0.424912006
Cholic acid	Cholic acid	UBERONBodyPartName	feces	2173	5114	0.424912006
Cholic acid	Cholic acid	TermsofPosition	not applicable	2143	5048	0.424524564
Cholic acid	Cholic acid	YearOfAnalysis	2017	1770	4272	0.414325843
Cholic acid	Cholic acid	LifeStage	Adolescence (8 yrs < x <= 18 yrs)	69	169	0.408284024
Cholic acid	Cholic acid	SampleExtractionMethod	ethanol-water (9:1)	1794	4423	0.405607054
Cholic acid	Cholic acid	SampleCollectionMethod	"swabs, dry"	1899	4696	0.404386712
Cholic acid	Cholic acid	MassSpectrometer	impact HD|MS:1002667	1593	3971	0.401158398
Cholic acid	Cholic acid	BiologicalSex	female	938	2372	0.39544688
Cholic acid	Cholic acid	BiologicalSex	not collected	185	477	0.387840671
Cholic acid	Cholic acid	MassSpectrometer	Q Exactive|MS:1001911	248	696	0.356321839
Cholic acid	Cholic acid	HealthStatus	not applicable	92	262	0.351145038
Cholic acid	Cholic acid	HealthStatus	chronic illness	47	140	0.335714286
Cholic acid	Cholic acid	HealthStatus	unhealthy (NOS)	414	1686	0.245551601
Cholic acid	Cholic acid	HumanPopulationDensity	Urban	815	3470	0.234870317
Cholic acid	Cholic acid	LifeStage	Early Childhood (2 yrs < x <=8 yrs)	20	93	0.215053763
Cholic acid	Cholic acid	DOIDCommonName	disease NOS	242	1428	0.169467787
Cholic acid	Cholic acid	YearOfAnalysis	2016	5	31	0.161290323
Cholic acid	Cholic acid	LifeStage	Early Adulthood (18 yrs < x <= 45 yrs)	139	995	0.139698492
Cholic acid	Cholic acid	DOIDCommonName	inflammatory bowel disease	11	84	0.130952381
Cholic acid	Cholic acid	LifeStage	Later Adulthood (>65 yrs)	40	325	0.123076923
Cholic acid	Cholic acid	LifeStage	Middle Adulthood (45 yrs < x <= 65 yrs)	113	933	0.121114684
Cholic acid	Cholic acid	DOIDCommonName	not applicable	2	132	0.015151515
Cholic acid	Cholic acid	DOIDCommonName	sleep deprivation	0	55	0
Cholic acid	Cholic acid	HumanPopulationDensity	not applicable	0	63	0
Cholic acid	Cholic acid	IonizationSourceAndPolarity	electrospray ionization (negative)	0	33	0
Cholic acid	Cholic acid	SampleExtractionMethod	acetonitrile (100%)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	acetonitrile-isopropanol-water (3:3:2)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	acetonitrile-water (7:3)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	ethanol-water (1:1)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	methanol (100%)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	methanol-acetonitrile (3:7)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	methanol-water (3:2)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	methanol-water (4:1)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	methanol-water (7:3)	0	6	0
Cholic acid	Cholic acid	SampleExtractionMethod	methanol-water (9:1)	0	3	0
Cholic acid	Cholic acid	SampleTypeSub1	tissue	0	138	0
Cholic acid	Cholic acid	YearOfAnalysis	2019	0	63	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	acetonitrile-isopropanol-water (3:3:2)	6	6	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	ethanol-water (1:1)	6	6	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	methanol (100%)	6	6	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	methanol-acetonitrile (3:7)	6	6	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	methanol-water (3:2)	6	6	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	methanol-water (4:1)	6	6	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	methanol-water (7:3)	6	6	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	methanol-water (9:1)	3	3	1
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HumanPopulationDensity	not applicable	61	63	0.968253968
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	YearOfAnalysis	2019	61	63	0.968253968
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	acetonitrile (100%)	5	6	0.833333333
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	acetonitrile-water (7:3)	5	6	0.833333333
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	inflammatory bowel disease	61	84	0.726190476
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleTypeSub1	tissue	61	138	0.442028986
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HealthStatus	chronic illness	61	140	0.435714286
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleCollectionMethod	"solid material, fresh"	61	397	0.153652393
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	MassSpectrometer	Q Exactive|MS:1001911	61	696	0.087643678
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	Middle Adulthood (45 yrs < x <= 65 yrs)	67	933	0.071811361
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	BiologicalSex	male	71	2264	0.031360424
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	Later Adulthood (>65 yrs)	6	325	0.018461538
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	TermsofPosition	not applicable	74	5048	0.014659271
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	IonizationSourceAndPolarity	electrospray ionization (positive)	74	5081	0.014564062
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	ChromatographyAndPhase	reverse phase (C18)	74	5114	0.014470082
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	NCBITaxonomy	9606|Homo sapiens	74	5114	0.014470082
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleType	animal	74	5114	0.014470082
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	UBERONBodyPartName	feces	74	5114	0.014470082
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	methanol-water (1:1)	6	634	0.009463722
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	disease NOS	10	1428	0.007002801
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HealthStatus	unhealthy (NOS)	10	1686	0.005931198
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HumanPopulationDensity	Urban	13	3470	0.003746398
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	MassSpectrometer	impact HD|MS:1002667	13	3971	0.003273735
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	YearOfAnalysis	2017	13	4272	0.003043071
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleExtractionMethod	ethanol-water (9:1)	13	4423	0.002939182
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleCollectionMethod	"swabs, dry"	13	4696	0.002768313
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleTypeSub1	biofluid	13	4976	0.00261254
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	BiologicalSex	female	3	2372	0.001264755
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	no disease reported	3	2960	0.001013514
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HealthStatus	healthy	3	2960	0.001013514
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	Early Adulthood (18 yrs < x <= 45 yrs)	1	995	0.001005025
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	BiologicalSex	not applicable	0	1	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	BiologicalSex	not collected	0	477	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	Crohn's disease	0	197	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	diabetes mellitus	0	56	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	not applicable	0	132	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	primary bacterial infectious disease	0	66	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	sleep deprivation	0	55	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	DOIDCommonName	ulcerative colitis	0	136	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HealthStatus	acute illness	0	66	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HealthStatus	not applicable	0	262	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HumanPopulationDensity	Rural	0	1138	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	HumanPopulationDensity	not collected	0	443	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	IonizationSourceAndPolarity	electrospray ionization (negative)	0	33	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	Adolescence (8 yrs < x <= 18 yrs)	0	169	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	Early Childhood (2 yrs < x <=8 yrs)	0	93	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	Infancy (<2 yrs)	0	1859	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	not applicable	0	1	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	not collected	0	735	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	LifeStage	not specified	0	4	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	MassSpectrometer	impact|MS:1002077	0	447	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	SampleCollectionMethod	"solid material, frozen"	0	21	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	TermsofPosition	not collected	0	66	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	YearOfAnalysis	2016	0	31	0
"Massbank:EA280204 Rosuvastatin|(E,3R,5R)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"	Rosuvastatin	YearOfAnalysis	2018	0	748	0
